noom glp-1 companion Noom's Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model Anyone else doing Noom w/GLP-1
Description
The use of GLP-1, GIP, and dual/triple receptor agonists, as well as intranasal insulin, requires further evaluation in large clinical trials
The weight data syncs with Apple Health, smoothly linking GLP-1 tracking to a larger health system
Consequently, SCFAs hold promise for glycemic control by modulating intestinal gluconeogenesis
Lunghi C, Moisan J, Grgoire J-P, Gunette L
Khan, MD, from the University of Pittsburgh Medical Center
